Literature DB >> 8280111

Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme.

X Y Hao1, M Widersten, M Ridderström, U Hellman, B Mannervik.   

Abstract

Qualitative and quantitative analyses of glutathione, glutathione transferases (GSTs) and other glutathione-linked enzymes in HeLa cells have been made in order to study their significance in cellular resistance to electrophilic cytotoxic agents. The cytosolic concentrations of three GSTs, GST M1-1 (53 +/- 9 ng/mg of cytosolic protein), GST P1-1 (11 +/- 3 ng/mg) and GST A1-1 (1.1 +/- 0.4 ng/mg) were quantified by isoenzyme-specific enzyme-linked immunoassays. Electrophoretic analysis and immunoblotting demonstrated another component, GST M3-3, which was identified by amino acid sequence analysis. GST M3-3 was quantified (1550 +/- 250 ng/mg) by slot-blot immunoanalysis and was the most abundant GST in HeLa cells. An additional cytosolic 13 kDa protein with high affinity for immobilized glutathione or S-hexyglutathione was found to be identical with a macrophage migration-inhibitory factor, previously identified as a lymphokine. Cells grown in roller bottles (HR) rather than in ordinary culture flasks contain a significantly lower concentration of all the GSTs and were found to be more sensitive to the cytostatic agents doxorubicin (2.3-fold), cisplatin (1.7-fold) and melphalan (1.4-fold). The cytosolic concentrations of glutathione reductase and glyoxalase I were also lower in HR cells, whereas the total glutathione concentration was unchanged and the glutathione peroxidase activity was increased. The results indicate that GSTs contribute to the cellular resistance phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8280111      PMCID: PMC1137790          DOI: 10.1042/bj2970059

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line.

Authors:  H Doostdar; S J Duthie; M D Burke; W T Melvin; M H Grant
Journal:  FEBS Lett       Date:  1988-12-05       Impact factor: 4.124

2.  Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells.

Authors:  M T Smith; C G Evans; P Doane-Setzer; V M Castro; M K Tahir; B Mannervik
Journal:  Cancer Res       Date:  1989-05-15       Impact factor: 12.701

3.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 4.  Glutathione transferases--structure and catalytic activity.

Authors:  B Mannervik; U H Danielson
Journal:  CRC Crit Rev Biochem       Date:  1988

5.  Elevation of the placental glutathione S-transferase form (GST-pi) in tumor tissues and the levels in sera of patients with cancer.

Authors:  S Tsuchida; Y Sekine; R Shineha; T Nishihira; K Sato
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

6.  Changes in expression and "de novo" synthesis of glutathione S-transferase subunits in cultured adult rat hepatocytes.

Authors:  Y Vandenberghe; A Foriers; V Rogiers; A Vercruysse
Journal:  Biochem Pharmacol       Date:  1990-02-15       Impact factor: 5.858

7.  Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

Authors:  W Y Weiser; P A Temple; J S Witek-Giannotti; H G Remold; S C Clark; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients.

Authors:  P A Speth; P C Linssen; J B Boezeman; H M Wessels; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi.

Authors:  K Berhane; B Mannervik
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

10.  Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.

Authors:  J A Moscow; A J Townsend; K H Cowan
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

View more
  8 in total

1.  Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.

Authors:  S R Tipnis; D G Blake; A G Shepherd; L I McLellan
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  Optimized heterologous expression of the human zinc enzyme glyoxalase I.

Authors:  M Ridderström; B Mannervik
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 3.  Mechanisms of drug resistance in colon cancer and its therapeutic strategies.

Authors:  Tao Hu; Zhen Li; Chun-Ying Gao; Chi Hin Cho
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

4.  Construction of a model cell line for the assay of MDR1 (multi drug resistance gene-1) substrates/inhibitors using HeLa cells.

Authors:  F Kugawa; T Suzuki; M Miyata; K Tomono; F Tamanoi
Journal:  Pharmazie       Date:  2009-05       Impact factor: 1.267

5.  Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue.

Authors:  M K Kelley; A Engqvist-Goldstein; J A Montali; J B Wheatley; D E Schmidt; L M Kauvar
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

6.  Delta 3, delta 2-enoyl-CoA isomerase is the protein that copurifies with human glutathione S-transferases from S-hexylglutathione affinity matrices.

Authors:  Y Takahashi; Y Hirata; Y Burstein; I Listowsky
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

Review 7.  An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance.

Authors:  Alessia Carta; Rachel Chetcuti; Duncan Ayers
Journal:  Genet Res Int       Date:  2014-12-04

Review 8.  Glutathione S-conjugates as prodrugs to target drug-resistant tumors.

Authors:  Emma E Ramsay; Pierre J Dilda
Journal:  Front Pharmacol       Date:  2014-08-11       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.